VOYA Investment Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-13,858
Closed -$276K 2977
2022
Q3
$276K Buy
13,858
+943
+7% +$12.4K ﹤0.01% 2404
2022
Q2
$89K Hold
12,915
﹤0.01% 2645
2022
Q1
$120K Hold
12,915
﹤0.01% 2488
2021
Q4
$184K Buy
12,915
+140
+1% +$2.42K ﹤0.01% 2542
2021
Q3
$296K Hold
12,775
﹤0.01% 2354
2021
Q2
$318K Buy
12,775
+20
+0.2% +$537 ﹤0.01% 2347
2021
Q1
$357K Buy
12,755
+5,823
+84% +$210K ﹤0.01% 2217
2020
Q4
$242K Buy
6,932
+1,956
+39% +$85.2K ﹤0.01% 2323
2020
Q3
$248K Buy
+4,976
New +$201K ﹤0.01% 2041

VOYA Investment Management's FMTX Position: Q4 2022 in Review

VOYA Investment Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 13,858 shares — an estimated $276K sold.

VOYA Investment Management first reported a position in FMTX in Q3 2020 and held it in 9 quarters. The position peaked at $357K in Q1 2021. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

  • VOYA Investment Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • VOYA Investment Management sold 13,858 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $276K.
  • VOYA Investment Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
  • VOYA Investment Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $357K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on VOYA Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.